So recently I have come across these two completely contradictory methods for treating cancer, one solely relying on application of D2R agonists (such as quinpirole) for treatment of lung cancer and the other one (that is recently published) claims the application of D2R antagonists (such as aspimozide and haloperidol) for treatment of pancreatic cancer. It is quite confusing to me how can two totally paradoxic methods have the same effect on the cancerous cells. Can someone guide me on which method is actually useful.
http://www.sciencedirect.com/science/article/pii/S1574789114002038
http://www.sciencedirect.com/science/article/pii/S0016508516349824